Clinical Trials Logo
  1. Home
  2. Acute Pain
  3. NCT04754451
  4. Details
NCT04754451 Clinical Trial

The Effect of Lidocaine Patch for Postoperative Pain

Acute Pain Clinical Trial

Official title:
The Efficacy and Safety of 5% Lidocaine Patch for Postoperative Pain in Unilateral Inguinal Herniorrhaphy

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04754451
Other study ID # LDPS
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date March 15, 2021
Est. completion date November 30, 2022

Study information
Verified date December 2023
Source Seoul National University Bundang Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The lidocaine patch is currently only permitted for post herpetic neuralgia but the investigators want to study its effectiveness in post operative pain after inguinal herniorrhaphy

Description:

After open unilateral inguinal herniorrhaphy, patients are randomly divided into group L and group P groups. Group L attaches two lidocaine patches for 12 hours, above and below the incision site. Group P attaches two placebo patches for 12 hours, above and below the incision site. Pain scores are recorded for 30 minutes, 2 hours, 24 hours, and 1 week after surgery.

Recruitment information / eligibility
Status Completed
Enrollment 32
Est. completion date November 30, 2022
Est. primary completion date November 23, 2022
Accepts healthy volunteers No
Gender All
Age group 19 Years to 80 Years
Eligibility Inclusion Criteria: - American Society of Anesthesiologists physical status I - II - Scheduled open unilateral herniorrhaphy Exclusion Criteria: - body mass index (BMI) < 18.5 or = 35 kg/m2 - severe renal or hepatic dysfunction - allergy to amide-based local anesthetic agents - taking class 1 antiarrhythmic drugs (tocainide and mexiletine, etc.)

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Group L
Attach two lidocaine patches for 12 hours, one above and below the incision site.

Locations
Country Name City State
Korea, Republic of Seoul National Universuty, Bundang Hospital Seongnam-si Gyonggido

Sponsors (2)
Lead Sponsor Collaborator
BON WOOK KOO SK Chemicals Co., Ltd.

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary The pain score VAS(visual analog scale) measurement for 24 hours after surgery(0-10) 0: no pain 10: severe pain 24 hours after the anesthesia finished.
Secondary The pain score VAS(visual analog scale) measurement for 24 hours after surgery(0-10) 0: no pain 10: severe pain 30 min after the anesthesia finished.
Secondary The pain score VAS(visual analog scale) measurement for 24 hours after surgery(0-10) 0: no pain 10: severe pain 2 hours after the anesthesia finished.
Secondary Total amount of cumulative analgesics total amount of analgesics are measured for 24 hours after surgery. 24 hours after the anesthesia finished.
See also
  Status Clinical Trial Phase
Completed NCT04484610 - Appropriate Opioid Quantities for Acute Pain - Pharmacist Study Phase 4
Recruiting NCT05054179 - Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain Phase 2/Phase 3
Completed NCT04548635 - VR for Burn Dressing Changes at Home Phase 2/Phase 3
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Completed NCT06054945 - Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
Completed NCT03825549 - A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing N/A
Completed NCT05995912 - Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain Phase 2
Recruiting NCT05589246 - Regional Analgesia in Combination With Cryoanalgesia to Prevent Acute Pain Following Nuss Procedure N/A
Recruiting NCT05572190 - Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects Phase 1
Terminated NCT04716413 - Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment Phase 4
Active, not recruiting NCT03537573 - Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care N/A
Not yet recruiting NCT06317844 - Examination of Psychological and Physiological Pathways Linking Gratitude and Pain N/A
Withdrawn NCT02957097 - Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures Phase 4
Completed NCT02565342 - Interscalene Brachial Plexus Block to Treat Pain After Clavicular Surgery Phase 4
Terminated NCT02599870 - Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures N/A
Completed NCT02984098 - 40% Orally Administered Dextrose Gel is More Effective Than 25% Dextrose Phase 4
Completed NCT02380989 - Integrative Ayurveda Healing Relieves Minor Sports Injury Pain Phase 2
Completed NCT02489630 - Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department Phase 4
Completed NCT03107338 - Preventive Treatment of Pain After Dental Implant Surgery Phase 4
Completed NCT02817477 - Intranasal Ketamine for Acute Traumatic Pain Phase 4